ایران دارو
دیران | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 22,480 2.98
Close Price: 22,480
Cash Flow
AGM
Interim
2026/04/19 Fiscal Year 2025/12/2112 Month / Audited | 2026/02/18 Fiscal Year 2025/12/2112 Month | ||
|---|---|---|---|
Cash Generated from Operations | 63.146 Billion | 1.059 Trillion | |
Income Taxes Paid | -125.457 Billion | -225.457 Billion | |
Net Cash Flow from Operating Activities | 1.719 Trillion | 833.879 Billion | |
Proceeds from Sale of Property, Plant and Equipment | 9.9 Billion | 9.9 Billion | |
Purchases of Property, Plant and Equipment | -131.628 Billion | -66.879 Billion | |
Purchases of Intangible Assets | -76.624 Billion | -76.361 Billion | |
Dividends Received | 72 Million | 72 Million | |
Cash Received from Income on Other Investments | 837 Million | 837 Million | |
Net Cash Flow from Investing Activities | -197.443 Billion | -132.431 Billion | |
Net Cash Flow before Financing Activities | 95.536 Billion | 701.448 Billion | |
دریافت های نقدی حاصل از افزايش سرمایه | 20.979 Billion | 20.979 Billion | |
Cash Received from Borrowings | 3.521 Trillion | 3.361 Trillion | |
Repayments of Borrowings (Principal) | -3.043 Trillion | -2.803 Trillion | |
Interest Paid on Borrowings | -1.444 Trillion | -1.091 Trillion | |
Dividends Paid | -558.712 Billion | -196.066 Billion | |
Net Cash Flow from Financing Activities | 439.885 Billion | -708.559 Billion | |
Net Increase (Decrease) in Cash | 535.421 Billion | -7.111 Billion | |
Cash at Beginning of Period | 98.84 Billion | 98.84 Billion | |
Effect of Exchange Rate Changes | -24.75 Billion | - | |
Cash at End of Period | 91.729 Billion | 98.84 Billion | |
Non-Cash Transactions | 346.477 Billion | 346.477 Billion |